Neuroone Medical Technologies Corp (NMTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has a cash flow conversion efficiency ratio of -0.216x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.53 Million) by net assets ($7.07 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Neuroone Medical Technologies Corp - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Neuroone Medical Technologies Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Neuroone Medical Technologies Corp carry for a breakdown of total debt and financial obligations.
Neuroone Medical Technologies Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuroone Medical Technologies Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chow Steel Industries Public Company Limited
BK:CHOW
|
0.041x |
|
Carbon Streaming Corp
NEO:NETZ
|
0.002x |
|
Desert Gold Ventures Inc
V:DAU
|
-0.433x |
|
Abko Co. Ltd
KQ:129890
|
-0.134x |
|
LIGHTON
PA:ALTAI
|
-0.386x |
|
IFCA MSC Bhd
KLSE:0023
|
0.002x |
|
Cipherlab Co Ltd
TWO:6160
|
-0.109x |
|
Gol Linhas Aéreas Inteligentes S.A
NYSE:GOLLQ
|
-0.024x |
Annual Cash Flow Conversion Efficiency for Neuroone Medical Technologies Corp (2010–2025)
The table below shows the annual cash flow conversion efficiency of Neuroone Medical Technologies Corp from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Neuroone Medical Technologies Corp market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $7.07 Million | $-2.84 Million | -0.401x | +97.01% |
| 2024-09-30 | $822.01K | $-11.01 Million | -13.396x | -549.64% |
| 2023-09-30 | $6.25 Million | $-12.89 Million | -2.062x | -163.38% |
| 2022-09-30 | $9.60 Million | $-7.52 Million | -0.783x | +40.35% |
| 2021-09-30 | $6.55 Million | $-8.60 Million | -1.313x | +20.82% |
| 2020-09-30 | $2.07 Million | $-3.43 Million | -1.658x | -138.02% |
| 2019-09-30 | $-1.24 Million | $-5.40 Million | 4.360x | +577.83% |
| 2018-09-30 | $-4.40 Million | $-2.83 Million | 0.643x | +711.35% |
| 2017-09-30 | $-266.22K | $-21.11K | 0.079x | -78.63% |
| 2016-09-30 | $-81.49K | $-30.23K | 0.371x | -49.84% |
| 2015-09-30 | $-35.39K | $-26.17K | 0.740x | -16.60% |
| 2014-09-30 | $-28.30K | $-25.09K | 0.887x | +11.30% |
| 2013-09-30 | $-17.24K | $-13.73K | 0.797x | 0.00% |
| 2012-09-30 | $-17.24K | $-13.73K | 0.797x | -90.48% |
| 2011-09-30 | $-3.28K | $-27.43K | 8.370x | +610.58% |
| 2010-09-30 | $-4.32K | $-5.09K | 1.178x | -- |
About Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more